We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
MHRA is asking for feedback on proposals to change the legal classification of Otrivine extra dual relief nasal spray solution from prescription only medicine (POM) to pharmacy only (P).
We are considering making Maloff Protect anti-malaria tablets available to buy from pharmacies. We always want to involve the public and healthcare professionals in decision that affect them. We want to know what you think a…
We are seeking views on amending fees for the regulation of medical devices. Please tell us what you think.
MHRA is asking for feedback on proposals to introduce proportionate fees for getting a notification from MHRA to put an e-cigarette on the market in the UK.
MHRA is asking for feedback on proposals to change the legal classification of Ibuprofen Seven Plus 200mg/5ml Oral Suspension
This consultation seeks views on the reduction of some fees for the regulation of medicines and the introduction of fees for online sellers of medicines (MLX 389).
The MHRA is asking for feedback on a proposal to allow wider access to naloxone for the purpose of saving life in an emergency.
Seeks views on the role and performance of the British Pharmacopoeia Commission (BPC)
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
We are asking the public for evidence about the use of hormonal pregnancy tests and possible adverse effects in pregnancy including birth defects.
This consultation (ARM88) welcomes views on proposals to classify Nexium Control 20mg Gastro-Resistant Tablets as a general sales list (GSL) product in the UK.
This consultation welcomes views on proposals to allow paramedics involved in maritime and coastguard agency contracted helicopter search and rescue operations to use medicines under patient group directions.
Seeks views on proposals to amend the Human Medicines Regulations 2012 so that PHE can develop and authorise Patient Group Directions.
MHRA is asking for feedback on proposals to reclassify Soleve Sunburn Relief Cutaneous Emulsion from pharmacy to general sales list.
This consulation seeks comments on the proposal to introduce a fee for each CFS application.
MHRA is asking for feedback on a proposal to simplify the information requirements for advertisements aimed at prescribers and suppliers of medicines.
This consultation is on proposals to amend the Human Medicines Regulations 2012 to allow the supply of salbutamol asthma inhalers to be kept in schools for emergency use.
MHRA seeks views on the listing of prescription medicines exempted from the safety feature and non-prescription medicines that must bear the safety feature (MLX387).
This consultation welcomes views on proposals to revoke ‘The Clinical Thermometers (EEC Requirements) Regulations 1993’ by November 2014.
MHRA has published a business engagement assessment on Composite Coordination Collection (CCC).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).